Diabetic patients with breast cancer who received insulin had a 1.65 (95% CI: 1.36–2.02; P < 0.001; I2 = 89.7%) times higher risk of overall mortality compared to those who did not use insulin. This evidence concerns the gene INS and breast cancer.